Non-invasive
reversal of intraluminal vas deferens polymer injection-induced azoospermiatechnology
Sujoy
K. Guha
Centre
for Biomedical Engineering, Indian Institute of Technology and All India
Institute of Medical Sciences, New Delhi-110016, India
Asian
J Androl 1999
Sep; 1: 131-134
Keywords:
vas
deferens; male contraceptive agents; maleic anhydrides; sterilization
reversal; palpation; electric stimulation
Abstract
Aim:
The
rationale and technique underlying a novel concept of non-invasive removal
of an intravasal vas deferens polymeric contraceptive drug to reverse drug
injection-induced azoospermia are explained. Thus the conventional methods
of surgical exploration to remove vas deferens plugs and intravasal injection
of solvents to flush out contraceptive drugs are to be replaced by steps
which will be readily accepted by subjects. Methods: The approach
is based upon the non-invasive application of specific forces to various
segments of the vas deferens so that non-sclerosing and non-tissue-adherent
compounds, in particular styrene maleic anhydride (SMA) can be expelled.
Forces are generated by palpation; percutaneous electrical stimulation;
vibration application; and percussion. The forces help to propel the intravasal
polymer towards the ejaculatory duct for expulsion during ejaculation.
All aspects of the total technique are clinically acceptable, simple,
atraumatic, unlikely to cause pain and discomfort even without tranquilizers,
local or general anaesthetics. The procedure
may be repeated several times in different sittings spaced apart
by about one week to achieve adequate plug expulsion. Results: Model
experiments demonstrated the feasibility of the concept. The polymer was
nonadherent and could be moved within the vas deferens by the application
of specific forces. Sufficient removal was possible to enable spermatic
fluid to be transported along a region previously occupied by the polymer.
A corroborating subhuman primate study by an independent investigator has
shown that the semen profile becomes normal following the reversal. Conclusion:
Adoption of the new technique may provide a means of non surgical restoration
of normal semen profile after a period of fertility control obtained by
intravasal drug injection.
1
Introduction
Contraception
following injection of a biologically active drug into the lumen of the
vas deferens was reported earlier[1]. The drug is a specific
preparation of styrene maleic anhydride (SMA) polymer mixed in dimethyl
sulphoxide[2] and is named RISUG. One administration of RISUG
in a therapeutic dose gives prolonged azoospermia and contraception. The
azoospermia being taken as the absence of intact functional sperms. Electrical
charge effect destroys spermatozoa[3]. Above threshold doses
of 60 mg or more of SMA in the monkey can give over five years of azoospermia
in all cases. Administration of SMA over the threshold level of 60 mg
in the monkey produces azoospermia for more than 5 years. Followup
of the Phase-I Clinical Trial[4] subjects until now
indicates that in higher doses azoospermia continues beyond seven years.
Phase-II Clinical Trial with 60 mg of SMA[5] and related two
years clinical trials with
dose variations[6] showed that in all subjects administered
60 mg or higher dose of SMA in a single injection have azoospermia and
contraception. Even all subjects who were treated three years ago are
having fertility control. In all the animal and clinical studies the drug
was injected by a direct observation of the vas deferens. The vas deferens
was accessed either by an approach as in conventional vasectomy or by
a technique similar to the Chinese method of
No Scalpel Vasectomy (NSV) which has been given the male `No Scalpel
Injection' (NSI). NSI differs from NSV in respect of the vas
deferens pickup forcep, the former being done with a forcep which does
not injure the vas deferens. Toxicological studies have shown the safety
of the drug and that within the vas deferens the drug does not sclerose
and also does not induce fibrosis[7].
Earlier,
the reversal was being affected by flushing out the drug by injecting the
solvent dimethyl sulphoxide[8,9] and alternatively with
sodium bicarbonate[10]. Experience with the injection method
of reversal shows that there are some difficulties. At the injection site
there is a nodule which regresses over several years. For reversal injection,
the vas deferens has to be approached at a point further proximal to the
testes than the injection point. The vas deferens narrows proximally. In
the animal studies this problem was not encountered because the injections
were given high up, that is, very close to the external (superficial) inguinal
ring, thus leaving considerable length of wide calibre vas deferens avialable
more proximal to the testes for reversal injection. In the human the contraceptive
injection must be given lower down, that is more proximal to the testes.
There is rapid narrowing of vas deferens further proximally. Therefore in
reversal injection, a
fairly large scrotal opening to get a clear view of the vas deferens is
required and considerable skill in injection is necessary. Consequently
the procedure, although quite feasible, does not meet the criteria of simplicity. In
the above background it is appropriate to devise a convenient non-invasive
reversal method. For the intraluminal vas deferens polymer
injection approach where styrene maleic anhydride is used, the properties
that SMA is not a sclerosing agent and also does not have adhesive character
become advantageous. Retention of the plug is a result of the intrinsic
bulk shear resistance and some anchorage provided by the invaginations in
the vas deferens mucosal wall. Therefore, if these retention effects
are overcome by suitable forces, the compound may be propelled towards the
distal end of the vas deferens, ultimately to be evacuated via the ejaculatory
duct. Azoospermia thereby will be terminated. From
earlier studies, both in rhesus monkey and the human it is known that total
removal of SMA from the vas deferens by external forces is not essential
to reverse azoospermia. If the net amount of SMA in the lumen is brought
to a low level, the bulk shear forces are so much reduced that with normal
muscular contraction of the vas deferens the remaining SMA is spontaneously
evacuated during ejaculations. Consequently the objective of the present
method is to reduce the amount of SMA in the vas deferens lumen instead
of total expulsion.
2
Materials and methods
For
the purpose of present discussion, the vas deferens may be considered
to be comprised of the following segments: scrotal segment extending from
the cauda epididymis to the external inguinal ring; inguinal segment from
the external inguinal ring to the internal inguinal ring; upper pelvic
segment from the internal inguinal ring up to the beginning of the dilated
ampulla of the vas deferens; and finally the terminal segment including
the ampulla and the ejaculatory duct. The scrotal vas deferens is almost
entirely palpable through the intact scrotal skin. The thin tortuous part
close to the epididymis can not be very well felt but the spermatic cord
is palpable and any pressure on the cord may be expected to be transmitted
to the vas deferens. Stabilizing the spermatic cord in a proximal site
by means of two fingers of one hand, a squeezing action progressing towards
the external inguinal ring can readily be applied percutaneously. This
`milking' action loosens the SMA depot and propels
the contents towards the external inguinal ring.
Under
normal circumstances the inguinal vas deferens can not be palpated. Its
course in the inguinal canal is well defined. Taking the pubic tubercle
and the anterior superior iliac spines as landmarks, the location of the
internal inguinal ring can reasonably be marked one centimeter above the
mid inguinal point. The reflected part of the inguinal ligament, conjoint
tendon of the internal oblique muscle and fascia transversalis provide
a firm base against which the spermatic cord can be pressed when force
is applied from the skin. In this procedure, the tips of all four palpating
fingers of both hands are placed over the surface marking of the spermatic
cord in the inguinal region. A peristaltic propulsive effect
within the vas deferens is generated by pressing down with the fingers
sequentially beginning from the finger over the external inguinal ring
and moving toward the finger tip over the internal ring. This sequence
is repeated about 15 times in one treatment course for each vas deferens.
Additional
clearance effect is derived from
contraction of the vas deferens musculature. Low frequency electric
stimulation produces contraction[11]. In the present exercise
the stimulation is delivered by means of surface electrodes. To obtain
a peristaltic effect a pair of stimulation electrodes are moved along
the surface from the location of the external inguinal ring to the internal
inguinal ring. Concurrently pressure is applied. To realize these two
effects concurrently an insulating rubber roller 20 mm diameter and 15
mm wide was prepared. On the outer cylindrical face of this roller, pairs
of small tags of electrically conducting rubber were affixed. An electrical
connection arrangement was made such that the electrode pair in contact
with the skin received the current from the electrical stimulator set
to deliver constant voltage pulses of 30 V amplitude and pulse repetition
rate of 15 Hz. By means of a handle, the roller was pressed over the inguinal
body surface and rolled upward and laterally from the external inguinal
ring to the internal inguinal ring with 20 repetitions of the procedure.
The
upper pelvic segment of the vas deferens is the least accessible to manipulations.
A combination of forces have been generated to loosen the SMA deposits
and to some extent propel the material. One of the
steps involves the placement of a mechanical vibrator delivering vibrations
with amplitude of 2 mm and frequency of 10 Hz at the surface marking of
the internal inguinal ring. The rationale underlying the step is that
the vibration is transmitted to the vas deferens through the skin and
subcutaneous tissue. Mechanical tissue properties of the vas deferens
differ from that of the surrounding tissues and this difference accounts
for the whipchord like feel of the vas deferens. In effect the vas
deferens becomes a distinct tube-like structure. Vibrations are preferentially
transmitted along such a structure. A light pressure on the skin just
proximal to the vibrator, that is toward the external ring, will enhance
the transmission toward the pelvic portion of the vas deferens. Vibration
of the wall loosens
the deposits in the lumen. Furthermore, vibration produces stretch effects
and can itself induce segmental contractions of the vas deferens. Concurrent
forceful percussion is applied to the abdominal wall in the suprapubic
region with the pleximeter finger well pressed down. Additionally the
subject is asked to cough. These last two manoeuvres raise pelvic pressures
transiently and are analogous to the removal of bronchial secretions by
percussion and coughing.
Finally
the terminal segment of the vas deferens is manipulated. Basically the
approach is similar to rectal prostatic massage. The difference being
that instead of massaging the prostate per se, the finger is moved in
a sweeping action from a superior lateral location to an inferior medial
location to follow the path of the ampulla of the vas deferens. Subjects
are placed in the left lateral or the knee-elbow position. Nominal suprapubic
abdominal compression is maintained to enhance easy accessibility of the
region of the ampulla of the vas deferens
by the palpating finger.
Because
of the small size of the monkey, the palpating finger in the rectum reaches
well beyond the region of the ampulla of the vas deferens and no assistant
devices are necessary. In the human the
palpating finger falls short of the full extent of the ampulla.
To
overcome the above difficulty construction of a rubber extension of the
finger was attempted but the feeling of contact pressure was lost. An experimental
device in the form of an extension
of the finger by a length of 15 mm has now been made. Five parallel rubber
balloons are embedded so that one end of the balloons press against the
rectal wall and the other end is in contact with the distal phalange pulp
of the palpating finger. Such a device gives extension along with a feel
of pressure and to some extent contours. Nevertheless
the device is still experimental and would be required only if restoration
of normal semen profile is quickly required. Otherwise the finger without special
provision will suffice.
3
Results
Some
aspects of the action of the physical forces were verified in experiments
on a rhesus monkey which had been previously injected with 100 mg of SMA
in each vas deferens. The vas deferens was exposed and sectioned above the
external inguinal ring. Percutaneous palpation of the scrotal segment of
the vas deferens produced oozing out of the SMA from the cut end of the
vas deferens. On the other side, the vas deferens was exposed and sectioned
at the internal inguinal ring. On applying pressure and electrical stimulation
percutaneously over the surface marking of the vas deferens between the
external and internal ring, SMA was seen to ooze out of the cut end of the
vas deferens at the internal inguinal ring. Allowing for some dilution effect
on account of residual polymer emerging with the spermatic fluid, the sperm
concentration in the fluid oozing out seems to be similar to that observed
when spermatic fluid which later on was squeezed out from a vas segment
proximal to the injection site. The volumes being extremely small, the assessment
of sperm concentration was only qualitative. Further verifications of the
action were left to an overall efficacy assessment carried out by an independent
investigator on studies on a different species of monkey and reported separately[12]. The
finding of that study showed that azoospermia reversal is feasible by the
non-invasive approach presented here.
4
Discussion
For
the SMA injection contraception, a comparison of the present non-invasive
method of reversal with the solvent injection approach of reversal has
already been given. It is of value to compare the new technique with the
reversal procedures for other vas deferens based contraceptive techniques.
Plugs
which serve purely as blocking agents can be removed by surgical manipulation[13].
In order to achieve azoospermia the plugs are either made long or of large
diameter of as much as 2.5 mm. With a fibrous nodule usually present at
the site of the insertion of the plug, the approach to the vas deferens
lumen and removal of the plug is not a simple exercise. Moreover, the
presence of any plug in the lumen of the vas deferens leads to hypolastic
changes in the vas deferens musculature with the wall becoming thin and
fragile. Surgical manipulations are therefore fraught with the danger
of rupture of the vas deferens necessitating reanastamosis. Valves[14]
placed in the
vas deferens are also not free from problems. Very often the valve is
surrounded by a tissue pseudocapsule and operation of the valve calls
for careful dissection to remove the encapsulating tissue. While carrying
out this process, the tubular ends of the valves are liable to slip out
of the lumen and replacement and anchorage is a difficult task.
Copper
wire inserted into the lumen of the vas deferens achieves fertility control[15]
but studies are still limited to animal models. Reversal is possible by
pulling out the wire, but a number of problems arise. The wire may fragment
inside the lumen and more commonly
the protruding end of the wire, kept outside of the vas deferens wall
by choice to facilitate removal, gets covered by tissue requiring careful
dissection.
Since
the other modes of vas deferens contraception do not have any convenient
reversal approach available, the somewhat elaborate steps in the present
technique become justifiable. Of the steps required to expel the plug
only the rectal palpation, although not painful, may generate some concern
amongst human acceptors. Prior counselling can overcome inhibitions inherent
in any rectal manipulations.
It
therefore can be concluded that an acceptable multi-modal procedure has
been devised to apply forces to all segments of the vas deferens to propel
non-adherent intraluminal vas deferens polymers towards the ejaculatory
duct. Use of this procedure can reduce the intraluminal vas deferens contents
to a low level so that azoospermia is reversed.
Carrying
out the procedure requires skill and there can be variabilities. To have
standardization, equipment has been designed which can deliver the electric
stimulation and pressure on the inguinal region as well as to perform the
rectal palpation forces in a reproducible form[16]. Nevertheless, experience
shows that such equipment is not essential and some variations in the force
of application only brings to a change in the number of treatment sessions
required without affecting the ultimate outcome.
References
[1]
Guha SK, Ansari S, Anand S, Farooq A, Misro MM, Sharma DN. Contraception
in male monkeys by intra-vas deferens injection of a pH lowering polymer.
Contraception 1985; 32: 109-18.
[2] Guha SK, inventor. Contraceptive
for use by a male. US patent 5488075. 1996.
[3] Guha SK. Electrical effects on mammalian sperms. Proc Ann Conf IEEE
Eng Med Biol 1988; 10: 1881-82.
[4] Guha SK, Singh G, Anand S, Ansari S, Kumar S, Koul V. Phase I clinical
trial of an injectable contraceptive for the male. Contraception 1993;
48: 367-75.
[5] Guha SK, Singh G, Ansari S, Kumar S, Srivastava A, Koul V, et al.
Phase II clinical trial of a vas deferens injectable contraceptive for
the male. Contraception 1997; 56: 245-50.
[6] Guha SK, Singh G, Srivastava A, Das HC, Bhardwaj JC, Mathur V, et
al. Two-year clinical efficacy trial with dose variations of a vas deferens
injectable contraceptive for the male. Contraception 1998; 58: 165-74.
[7] Sethi N, Srivastava RK, Singh RK, Bhatia GS, Sinha N. Chronic toxicity
of styrene maleic anhydride. a male contraceptive, in rhesus monkeys (Macaca
mulatta). Contraception 1990; 42: 337-47.
[8] Misro M, Guha SK, Singh H, Mahajan S, Ray AR, Vasudevan P. Injectable
non-occlusive chemical contraception in the male-I. Contraception 1979;
20: 467-73.
[9] Sethi N, Srivastava RK,
Singh RK. Histological changes
in the vas deferens of rats after injection of a new male antifertility
agent SMA and its reversibility. Contraception 1990;41: 333-9.
[10] Koul V, Srivastav A, Guha SK. Reversibility with sodium bicarbonate
of styrene maleic anhydride, an intravasal injectable contraceptive, in
male rats. Contraception 1998; 58: 227-31.
[11] Kihara K, Sato K, Ando M, Ushiyama T, Azuma H, Oshima H. A new method
to generate canine seminal emission and its application to men: direct
electrical stimulation of the vas deferens. J Androl 1994; 15: 479-83.
[12] Lohiya NK, Manivanan B, Mishra PK, Pathak N, Balasubramanian SP.
Intravasal contraception with styrene maleic anhydride and its noninvasive
reversal in langur monkeys (Presbytis entellus entellus). Contraception
1998; 58: 119-28.
[13] Zhao SC, Zhang SP,
Yu RC. Intravasal
injection of formed-in-place silicone rubber as a method of vas occlusion.
Int J Androl 1992; 15: 460-64.
[14] Free MJ. Reversible intravasal devices: state of the art. In: Sciarra
JJ, Zatuchni GI, Speidel JJ, editors. Reversal of Sterilization. Maryland:
Harper Row Publishers;
1977. p 64-9.
[15] Kapur MM, Mokkapati S, Farooq A, Ahsan RK,
Laumas KR. Copper intravas device (IVD) and male
contraception. Contraception 1984; 29: 45-54.
[16] Guha SK, inventor. A device for restoration of male fertility. Indian
patent 928/Del/97. 1997.
Correspondence
to Dr. S.K. Guha.
Tel: +91-11-658 1823 Fax: +91-11-686 2037
E-mail: guhask@cbme.iitd.ernet.in
Received
1999-06-29 Accepted 1999-08-25
|